Phosphoinositide 3 Kinase, p85 beta (PI-3 Kinase p85 beta, PI3 Kinase p85 beta Subunit, PI3 Kinase p85 Subunit beta, PI3K, p85 beta, P85B, Phosphatidylinositol 3 Kinase Regulatory beta Subunit, Phosphatidylinositol 3 Kinase Regulatory Subunit beta, Phosphatidylinositol 3 Kinase Regulatory Subunit Polypeptide 2, Phosphoinositide 3 Kinase Regulatory Subunit 2 (beta), Phosphoinositide 3 Kinase Regulatory Subunit Polypeptide 2 (p85 beta), PIK3R2, PtdIns-3-kinase p85 beta) (HRP)

Applications:|Suitable for use in Immunohistochemistry, Immunoprecipitation and Western Blot. Other applications not tested. ||Recommended Dilutions:|Immunoprecipitation: 10ug/ml|Western Blot: 1:500-1:1000|Immunohistochemistry: Frozen sections|Optimal dilutions to be determined by the researcher. ||Hybridoma: |NS1 myeloma cells with spleen cells from Balb/c mice.||Storage and Stability:|Store product at 4°C if to be used immediately within two weeks. For long-term storage, aliquot to avoid repeated freezing and thawing and store at -20°C. Aliquots are stable at -20°C for 12 months after receipt. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. Note: Sodium azide is a potent inhibitor of peroxidase and should not be added to HRP conjugates. |For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.||Note: Applications are based on unconjugated antibody.